ArticleBMC public health2025
Factors associated with loss to follow-up among people living with HIV at public health facilities in Manaus, Brazil: a multicentric study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lenacapavir Use in France: A National, Observational Study (LENAddOn).Open forum infectious diseases · 2026Trial
- The HIV/AIDS Epidemiological Challenges: Why is HIV Incidence Rising While AIDS Incidence and Mortality are Declining in Brazil?Journal of community health · 2026Article
- Strategies to improve retention in care among people living with HIV at health facilities in Manaus, Brazil: insight from health care providers.AIDS research and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLoss to follow-up (LTFU) among people living with HIV (PLHIV) impact on the quality of life of PLHIV, and consequently on the ineffectiveness of strategies to control the HIV/AIDS epidemic.
methodsThe aim of the study was to investigate the factors associated with LTFU among PLHIV treated at health facilities for PLHIV in Manaus. This was a multicenter cohort study that involved the review of medical records in referral units for monitoring PLHIV in the district of Manaus. PLHIV who did not collect ARVs in a period of more than 90 days or did not attend a scheduled appointment in six months were considered LTFU. Sociodemographic, epidemiological, behavioral, diagnostic and clinical follow-up variables of all study participants were analyzed. Cox proportional hazards regression was used to determine factors associated with LTFU. 234 semi-structured interviews were conducted with PLHIV in LTFU status to explore reasons for LTFU.
resultsOf the 2085 PLHIV enrolled, 1534 (73.58%) were male, the median age was 36.75 years, and 701 (33.72%) were < 30 years old, 1226 (58.80%) were single, and the majority had a first baseline CD4 count less than 500c/ µ l. A total of 465 (22.30%) become LTFU. The main factors associated with LTFU included being single (hazard ratio (HR) = 3.51, 95% confidence interval (CI): 1.69-7.36, p = 0.01), low education level (HR = 2.1, 95% CI: 0.62-3.36, p = 0.00), and having an undetectable last viral load result (HR = 2.04; 95% CI, 1.05-3.95; p = 0.04). Discrimination, stigma, lack of family or social support, illicit drug use, low economic conditions, adverse effects of antiretroviral therapy, feeling healthy, and poor patient-provider relationship were the main reasons for LTFU reported from semi-structured interviews conducted with PLHIV in LTFU status.
conclusionsThe phenomenon of LTFU among PLHIV is a reality in the health facilities of Manaus. This phenomenon can be predicted based on sociodemographic and clinical characteristics, as well as socioeconomic factors. To effectively reduce LTFU among PLHIV in Manaus, it is recommended to reinforce appropriate measures for risk groups and improve the quality-of-service provision to PLHIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.